You are here

Editorial

Open Public Hearing No. 4: My Fight for Nonprescription Mevacor

David Nash, MD, MBA
PDF version: 
David Nash, MD, MBA, recounts his testimony before the FDA in which he supported bringing lovastatin (Mevacor) over the counter.